Skip to content

Prevention of Iron Deficiency in 2nd Year of Life

Effectiveness of Iron Supplementation in the Second Year of Life for Prevention of Iron Deficiency

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00479102
Enrollment
Unknown
Registered
2007-05-25
Start date
2007-05-31
Completion date
Unknown
Last updated
2007-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Iron Deficiency

Keywords

Iron supplementation, Babies, Prevention

Brief summary

Healthy babies(age 8-18 months) following a routine blood count, with no anemia or iron deficiency, will be randomly placed in two groups. Group 1 will receive a 3 months preventive dose of an iron preparation (Ferripel 3 iron polysaccharide complex). Group 2 will be followed up as a control group. Following a nutritional questionnair, parents of all babies will receive instruction regarding appropriate nutrition in the 2nd year of life. A follow-up blood count will be taken from all participating babies 3 months after recruitment. The study aims to evaluate effectiveness of iron supplementation in the 2nd year of life. The hypothesis is that babies who receive iron supplementation in the 2nd year of life are less likely to develop iron deficiency or anemia.

Interventions

DRUGFerripel-3 - iron polysaccharide complex for prevention

Sponsors

Soroka University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Months to 18 Months
Healthy volunteers
Yes

Inclusion criteria

* Healthy babies without iron deficiency

Exclusion criteria

* Babies with iron deficiency or chronic diseases, premature babies and babies with hereditary hematological disease

Countries

Israel

Contacts

Primary ContactHanna Shalev, MD
hannash@clalit.org.il972-52-8504058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026